AI tool can predict Barrett’s esophagus recurrence after therapy with 90% accuracy

A new artificial intelligence (AI)-based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett’s esophagus (BE)-related dysplasia and early esophageal adenocarcinoma. BE is the only known condition that precedes esophageal adenocarcinoma—an aggressive cancer with high mortality rates.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup